{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:27:46Z","timestamp":1786480066852,"version":"build-2736575974"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["LISBOA2030-FEDER-00862500-14998"],"award-info":[{"award-number":["LISBOA2030-FEDER-00862500-14998"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Biotechnology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.tibtech.2026.07.029","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:14:05Z","timestamp":1786421645000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Organoids cannot replace physiology in cancer drug development"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8422-6792","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Conde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tibtech.2026.07.029_bb0005","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41573-025-01317-y","article-title":"Human organoids as 3D in vitro platforms for drug discovery: opportunities and challenges","volume":"25","author":"Wang","year":"2026","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tibtech.2026.07.029_bb0010","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s43586-022-00118-6","article-title":"A guide to the organ-on-a-chip","volume":"2","author":"Leung","year":"2022","journal-title":"Nat. Rev. Methods Primers"},{"key":"10.1016\/j.tibtech.2026.07.029_bb0015","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1158\/0008-5472.CAN-15-1518","article-title":"Dual HER2 targeting with trastuzumab and liposomal-encapsulated doxorubicin (MM-302) demonstrates synergistic antitumor activity in breast and gastric cancer","volume":"76","author":"Espelin","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.tibtech.2026.07.029_bb0020","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1158\/1078-0432.CCR-16-3193","article-title":"64Cu-MM-302 positron emission tomography quantifies variability of enhanced permeability and retention of nanoparticles in relation to treatment response in patients with metastatic breast cancer","volume":"23","author":"Lee","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tibtech.2026.07.029_bb0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tibtech.2026.07.029_bb0030","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/s41565-024-01673-7","article-title":"A large-scale machine learning analysis of inorganic nanoparticles in preclinical cancer research","volume":"19","author":"Mendes","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.tibtech.2026.07.029_bb0035","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/s41591-025-03637-3","article-title":"A benchmarking crisis in biomedical machine learning","volume":"31","author":"Mahmood","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.tibtech.2026.07.029_bb0040","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/d41586-025-02215-4","article-title":"How to de-Americanize global science","volume":"643","author":"Conde","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.tibtech.2026.07.029_bb0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/d41586-026-01411-0","article-title":"Europe must not sabotage its scientific future","volume":"653","author":"Conde","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.tibtech.2026.07.029_bb0050","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/s41591-026-04309-6","article-title":"Five tenets for advancing evidence-based precision medicine","volume":"32","author":"Coral","year":"2026","journal-title":"Nat. Med."}],"container-title":["Trends in Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167779926003252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167779926003252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T19:32:55Z","timestamp":1786476775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167779926003252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":10,"alternative-id":["S0167779926003252"],"URL":"https:\/\/doi.org\/10.1016\/j.tibtech.2026.07.029","relation":{},"ISSN":["0167-7799"],"issn-type":[{"value":"0167-7799","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Organoids cannot replace physiology in cancer drug development","name":"articletitle","label":"Article Title"},{"value":"Trends in Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tibtech.2026.07.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}